| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternative activation in systemic juvenile idiopathic arthritis monocytes
|
Macaubas, Claudia
|
|
2012
|
142 |
3 |
p. 362-372
11 p.
|
artikel
|
| 2 |
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
|
Allard, Sabine D.
|
|
2012
|
142 |
3 |
p. 252-268
17 p.
|
artikel
|
| 3 |
Chronic Rotavirus Infection in an Infant with Severe Combined Immunodeficiency: Successful Treatment by Hematopoietic Stem Cell Transplantation
|
Patel, Niraj C.
|
|
2012
|
142 |
3 |
p. 399-401
3 p.
|
artikel
|
| 4 |
Combination therapy with InsB9-23 peptide immunization and CTLA4-IgG does not reverse diabetes in NOD mice
|
Schneider, Darius A.
|
|
2012
|
142 |
3 |
p. 402-403
2 p.
|
artikel
|
| 5 |
Defects in acute responses to TLR4 in Btk-deficient mice result in impaired dendritic cell-induced IFN-γ production by natural killer cells
|
Ní Gabhann, Joan
|
|
2012
|
142 |
3 |
p. 373-382
10 p.
|
artikel
|
| 6 |
DNA-responsive inflammasomes and their regulators in autoimmunity
|
Choubey, Divaker
|
|
2012
|
142 |
3 |
p. 223-231
9 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2012
|
142 |
3 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo
|
Moise, Leonard
|
|
2012
|
142 |
3 |
p. 320-331
12 p.
|
artikel
|
| 9 |
Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages
|
Kadowaki, Takeshi
|
|
2012
|
142 |
3 |
p. 296-307
12 p.
|
artikel
|
| 10 |
IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE
|
Grönwall, Caroline
|
|
2012
|
142 |
3 |
p. 390-398
9 p.
|
artikel
|
| 11 |
IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction — A comparative study of human clinical-applicable DC
|
Boks, Martine A.
|
|
2012
|
142 |
3 |
p. 332-342
11 p.
|
artikel
|
| 12 |
Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis
|
Zhu, Bing
|
|
2012
|
142 |
3 |
p. 351-361
11 p.
|
artikel
|
| 13 |
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients
|
Christophi, George P.
|
|
2012
|
142 |
3 |
p. 308-319
12 p.
|
artikel
|
| 14 |
IVIg-mediated inhibition of antigen presentation: Predominant role of naturally occurring cationic IgG
|
Trépanier, Patrick
|
|
2012
|
142 |
3 |
p. 383-389
7 p.
|
artikel
|
| 15 |
Linker for activation of T cells is displaced from lipid rafts and decreases in lupus T cells after activation via the TCR/CD3 pathway
|
Abdoel, Nursamaa
|
|
2012
|
142 |
3 |
p. 243-251
9 p.
|
artikel
|
| 16 |
Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T Cells through the ICOSL/ICOS axis
|
Nie, Xiaomeng
|
|
2012
|
142 |
3 |
p. 269-279
11 p.
|
artikel
|
| 17 |
Live Attenuated Influenza Virus (LAIV) induces different mucosal T cell function in nonsmokers and smokers
|
Horvath, Katherine M.
|
|
2012
|
142 |
3 |
p. 232-236
5 p.
|
artikel
|
| 18 |
Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE
|
Perl, Andras
|
|
2012
|
142 |
3 |
p. 219-222
4 p.
|
artikel
|
| 19 |
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
|
Barr, Paul M.
|
|
2012
|
142 |
3 |
p. 237-242
6 p.
|
artikel
|
| 20 |
Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival
|
Sairafi, Darius
|
|
2012
|
142 |
3 |
p. 343-350
8 p.
|
artikel
|
| 21 |
Tolerance induced by anti-DNA Ig peptide in (NZB×NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells
|
Yu, Yiyun
|
|
2012
|
142 |
3 |
p. 291-295
5 p.
|
artikel
|
| 22 |
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
|
Hofstra, J.J.
|
|
2012
|
142 |
3 |
p. 280-290
11 p.
|
artikel
|
Tijdschrift beschrijving